Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × Exercise × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 32 Motor Activity 22 Breast Neoplasms 5 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Neoplasms 3 Carcinoma, Renal Cell 3 Ovarian Neoplasms 2 Kidney Neoplasms 2 Fatigue 2 Thyroid Neoplasms 1 Testicular Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Obesity 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Metabolic Syndrome 1 Mesothelioma, Malignant 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Insulin Resistance 1 Hypoxia 1 Endometrial Neoplasms 1 Diabetes Mellitus 1 Cardiovascular Diseases 1 Carcinoma, Transitional Cell 1

Interventions

TH 302 2 Ipilimumab 1 Injections 1 Exercise 1 Circulating Tumor DNA 1 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 1 3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03365076 2023-01-09

EXIPOX

University Hospital of North Norway

Phase NA Terminated

Hypoxia, Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡